COMMUNIQUÉS West-GlobeNewswire

Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules
02/06/2026
$8.5 million upfront with up to approximately $15.1 million of potential additional gross proceeds upon the exercise in full of warrants Net proceeds anticipated to extend cash runway into first quarter of 2027, beyond [...]
GENFIT Annual General Meeting of June 15, 2026 - Shareholders' letter
02/06/2026
Dear Shareholders, We are pleased to send you, in the attached document, GENFIT’s Shareholders’ Letter published ahead of our Annual General Meeting to be held on June 15, 2026. This letter outlines the key elements [...]
GENFIT : Assemblée Générale Mixte du 15 juin 2026 - Lettre aux actionnaires
02/06/2026
Chers Actionnaires, Nous avons le plaisir de vous adresser, en pièce jointe, la Lettre aux actionnaires de GENFIT publiée à l’approche de notre Assemblée Générale Mixte du 15 juin 2026. Cette lettre revient sur les [...]
AB Science : Stonegate Capital Partners updates its coverage of AB Science’s stock with a target price of EUR 4.25 per share
02/06/2026
PRESS RELEASE STONEGATE CAPITAL PARTNERS UPDATES ITS COVERAGE OF AB SCIENCE’S STOCK WITH A DISCOUNTED CASH FLOW VALUATION MID-POINT OF EUR 4.25 PER SHARE Paris, June 2 nd , 2026, 6pm CET AB Science SA (Euronext - [...]
AB Science : Stonegate Capital Partners actualise sa couverture de l'action AB Science avec un objectif de cours de 4,25 EUR par action
02/06/2026
COMMUNIQUÉ DE PRESSE STONEGATE CAPITAL PARTNERS ACTUALISE SA COUVERTURE DE L'ACTION AB SCIENCE AVEC UN OBJECTIF DE COURS DE 4,25 EUR PAR ACTION EN VALEUR MÉDIANE, SUR LA BASE DES FLUX DE TRÉSORERIE ACTUALISÉS Paris, 2 [...]
CROSSJECT met à disposition les réponses aux questions de ses actionnaires préalablement à son Assemblée Générale
02/06/2026
CROSSJECT met à disposition les réponses aux questions de ses actionnaires préalablement à son Assemblée Générale Dijon, France 02 juin 2026 (17h45 CET) -- CROSSJECT (ISIN: FR0011716265; Euronext: ALCJ) , la société [...]
Update on the Carbios - Wankai project in China
02/06/2026
Clermont-Ferrand (France), 2 June 2026 (05:45 pm CEST). Carbios (Euronext Growth Paris: ALCRB) provides an update on the progress of its strategic partnership with Wankai New Materials (“ Wankai ”) in the field of PET [...]
Point d’avancement sur le projet Carbios - Wankai en Chine
02/06/2026
Clermont-Ferrand (France), 2 juin 2026 (17h45 CEST). Carbios (Euronext Growth Paris : ALCRB) fait le point sur l’avancement de son partenariat stratégique avec Wankai New Materials (« Wankai ») dans le domaine du [...]
NexTel Medical Corp. Executes Definitive Purchase Agreements to Acquire JumpstartRx and NueVistraMed, Expanding Telehealth Footprint and Accelerating Maxasome™ Commercialization
02/06/2026
Acquisitions bring immediate $135,000 in monthly recurring revenue prior to near-term scaling initiatives; Transaction structured as non-dilutive to $MAJI shareholders. ORLANDO, Fla., June 02, 2026 (GLOBE NEWSWIRE) -- [...]
FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for Patients
02/06/2026
Guidance shows how sponsors can build on existing science, reducing redundant testing and accelerating treatments for patients with rare and life-threatening diseases Silver Spring, MD, June 02, 2026 (GLOBE NEWSWIRE [...]
Zealand Pharma to participate in the Goldman Sachs Global Healthcare Conference
02/06/2026
Press release – No. 12 / 2026 Zealand Pharma to participate in the Goldman Sachs Global Healthcare Conference Copenhagen, Denmark, June 2, 2026 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology [...]
Philips receives FDA 510(k) clearance for Elevate Plus for EPIQ Elite and Affiniti, delivering AI advancements in general imaging ultrasound
02/06/2026
June 2, 2026 Philips receives FDA 510(k) clearance for Elevate Plus for EPIQ Elite and Affiniti, delivering AI advancements in general imaging ultrasound AI-powered workflow automation helps clinicians acquire high- [...]
Oncolytics Biotech® Announces Appointment of Steve Glover to Board of Directors and Promotion of John McAdory to Chief Operating Officer
02/06/2026
SAN DIEGO, June 02, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage company developing pelareorep, an investigational, systemically active [...]
Signati™ Medical Receives FDA IDE Approval for Pivotal Study of the Separo™ Vessel Sealing System
02/06/2026
Providence, RI, June 02, 2026 (GLOBE NEWSWIRE) -- Signati™ Medical, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s Investigational Device Exemption (IDE) application for [...]
Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website
02/06/2026
New dashboard at betabionics.com shows every patient, every baseline, every outcome, with no filters and no fine print IRVINE, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering [...]
Scene Health Releases New Guide on Medication Adherence Support for Leaders Advancing Rural Health Transformation
02/06/2026
BALTIMORE, June 02, 2026 (GLOBE NEWSWIRE) -- Scene Health announces the release of its new guide, Transforming Rural Healthcare through Medication Adherence Support , designed for U.S. health leaders strengthening their [...]
Kura Oncology and Kyowa Kirin Announce Publication in Blood of Ziftomenib plus Venetoclax / Azacitidine Combination in Patients with R/R NPM1-m AML
02/06/2026
– 87% ORR and 70% CRc in venetoclax-naïve and 48% ORR and 24% CRc in venetoclax-experienced patients at the recommended 600 mg once-daily dose – – Central MRD negativity in 75% of CRc responders with no prior venetoclax [...]
Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026
02/06/2026
New findings from the industry’s largest real-world TMS database reinforce NeuroStar’s leadership in advancing evidence-based mental health care MALVERN, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ [...]
Inventiva Announces Trading Resumption of its Ordinary Shares on Euronext Paris
02/06/2026
Daix (France), New York City (New York, United States), June 2, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA ) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of [...]

Pages